CORT - Corcept Therapeutics GAAP EPS of $0.28 beats by $0.02 revenue of $135.4M beats by $6.1M
2024-02-15 16:23:49 ET
More on Corcept Therapeutics
- Corcept Therapeutics Q4 2023 Earnings Preview
- Corcept Therapeutics reports prelim Q4 rev above estimate
- Seeking Alpha’s Quant Rating on Corcept Therapeutics
- Historical earnings data for Corcept Therapeutics
- Financial information for Corcept Therapeutics